维普中文期刊产品整合服务
73篇 您的检索式:作者名="de Bono J"
    题名 作者 年代 出处 被引量
1Coronary artery stents and non-cardiac surgery 显示文摘Howard-Alpe GM de Bono J Hudsmith L 2007Br J Anaesth2007,98,5:1
2Coronary artery stents and non-cardiac surgery 显示文摘Howard Alpe GM de Bono J Hudsmith L 2007Br J Anaesth2007,98,5:1
3Prednisone plus cabazitaxel or mitoxantrone for metastatic castration- resistant prostate cancer progressing after docetaxel treat- ment : a randomised open-label trial 显示文摘de Bono J S Oudard S Ozguroglu M 2010Lancet2010,376,9747:1
4CYP17 blockade by abira-terone:further evidence for frequent continued hormone-dependence in castration-resistant prostate cancer显示文摘Ang J E Olmos D de Bono J S 2009Br J Cancer2009,100,5:1
5Abiraterone in metastatic prostate cancer without previous chemotherapy 显示文摘Ryan C J Smith M R de Bono J S 2013N Engl J Med2013,368,2:1
6Abiraterone and in- creased survival in metastatic prostate cancer 显示文摘de Bono JS Logothetis C J Molina A 2011N Engl J Med2011,364,19:1
7Prednisone plus cabazita- xel or mitoxantrone for metastatic castration - resistant prostate canc- er progressing after docetaxel treatment : a randomised open - label trial显示文摘de Bono J S Oudard S Ozguroglu M 2010Lancet2010,376,9747:1
8Perioperative management of anticoagulation during device implantation-the UK perspective显示文摘de Bono J Nazir S Ruparelia N 2010Pacing Clin Electrophysiol2010,33,4:1
9The ErbB receptor family: a therapeutic target for cancer 显示文摘De Bono J S Rowinsky E K 2002Trends Mol Med2002,8,4:1
10Making sense of antisense显示文摘Vidal L Blagden S Attard G de Bono J 2005Eur J Cancer2005,41,18:1
11Time course of attentional bias for threat information in non-clinical anxiety显示文摘Mogg K Bradley BP de Bono J 1997Behav Res Tiler1997,35,4:1
12On the micromechanics of one-dimensional normal compression显示文摘MCDOWELL G DE BONO J P 2013Grotechnique2013,63,11:1
13Abiraterone and in- creased Survival in metastatic prostate cancer显示文摘De Bono JS Logothetis C J Molina A 2011N Engl J Med2011,364,21:1
14The ErbB receptor family:a therapeutic target for cancer显示文摘De Bono J S Rowinsky E K 2002Trends Mol Med2002,8,4:1
15Targeting the HGF/c-Met axis: state of play 显示文摘Yap T A de Bono J S 2010Mol Cancer Ther2010,9,5:1
16Translating scientific advancement into clinical benefit for castration-resistant prostate cancer patients显示文摘ATTARD G DE BONO J S 0,,:1
17Abiraterone and increased survival in metastatic prostate cancer显示文摘DE BONO J S LOGOTHETIS C J MOLINA A 0,,21:1
18Abiraterone and increased survival in wctastatic prostate cancer 显示文摘de Bono JS Logothetis C J Molina A 2011N Engl J Med2011,364,21:1
19Interim analysis (IA) results of COU-AA-302, a randomized, phase III study of abiraterone acetate (AA) in chemotherapy-naive patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) 显示文摘Ryan C J Smith M R De Bono J S 2012Asco Meeting Abstracts2012,,30:1
20Abiraterone and in- creased survival in metastatic prostate cancer 显示文摘de Bono JS Logothetis C J Molina A 2011N Engl J Med2011,364,21:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费